首页> 外国专利> METHOD FOR SCREENING COMPOUNDS REGULATING THE EXPRESSION OF HUMAN-INDUCIBLE NITRIC OXIDE SYNTHASE

METHOD FOR SCREENING COMPOUNDS REGULATING THE EXPRESSION OF HUMAN-INDUCIBLE NITRIC OXIDE SYNTHASE

机译:调控人类诱导型一氧化氮合酶表达的化合物筛选方法

摘要

A transformant prepared by constructing a plasmid wherein a human-inducible nitric oxide synthase (hiNOS) structural gene has been substituted by a luciferase structural gene which is a reporter gene while sustaining the functions of the 5'-promoter region and the 3'-untranslated region of the hiNOS gene and then stably trasferring the plasmid into an established human cell line. This transformant expresses selectively the reporter gene in the presence of an inducer. By determining the expression dose of the reporter gene owing to this transformant, it is possible to conveniently and sensitively screen compounds seemingly being useful in treating inflammation or sepsis through the inhibition of the expression of hiNOS. By inducing the expression thereof, further, it is possible to conveniently and sensitively screen compounds seemingly being useful as antitumor agents or antiviral agents or in treating re-angiostenosis inhibition.
机译:通过构建质粒而制备的转化体,其中人诱导型一氧化氮合酶(hiNOS)结构基因已被荧光素酶结构基因取代,该荧光素酶结构基因是报告基因,同时维持了5'-启动子区域和3'-非翻译区的功能hiNOS基因的区域,然后稳定地将质粒转移到已建立的人类细胞系中。该转化体在诱导剂存在下选择性表达报道基因。通过确定归因于该转化体的报道基因的表达剂量,可以通过抑制hiNOS的表达方便而灵敏地筛选看似可用于治疗炎症或败血症的化合物。此外,通过诱导其表达,可以方便和灵敏地筛选看似可用作抗肿瘤剂或抗病毒剂或用于治疗再血管狭窄抑制的化合物。

著录项

  • 公开/公告号EP0864648B1

    专利类型

  • 公开/公告日2006-11-29

    原文格式PDF

  • 申请/专利权人 DAIICHI ASUBIO PHARMA CO LTD;

    申请/专利号EP19970941189

  • 申请日1997-09-18

  • 分类号C12N15/09;C12N15/11;C12Q1/02;C12Q1/25;G01N33/53;C07C50/06;C07C50/30;C07C66/00;C07D295/16;A61K31/12;C12N9/02;G01N33/50;

  • 国家 EP

  • 入库时间 2022-08-21 20:51:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号